interleukin-8 and Oral-Submucous-Fibrosis

interleukin-8 has been researched along with Oral-Submucous-Fibrosis* in 4 studies

Other Studies

4 other study(ies) available for interleukin-8 and Oral-Submucous-Fibrosis

ArticleYear
Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.
    Environmental toxicology, 2018, Volume: 33, Issue:1

    Oral submucous fibrosis (OSF) has been indicated as one of the oral potentially malignant disorders. Epidemiological studies have attributed this pathological fibrosis to the habit of areca nuts chewing, which causes chronic inflammation and persistent activation of myofibroblasts in the oral cavity. Hence, it is crucial to find an effective intervention to ameliorate inflammation in order to prevent the malignant progression of OSF. In this study, we assessed the anti-inflammatory effect of the immunomodulatory protein, GMI, extracted from Ganoderma microsporum on the expression proinflammatory cytokines and the myofibroblast characteristics in human fibrotic buccal mucosal fibroblasts (fBMFs). Our results demonstrated that the expression level of interleukin (IL)-6 and IL-8 were decreased after exposure of GMI and the myofibroblast activities, including collagen gel contraction, migration, invasion, and wound healing abilities were inhibited as well. Furthermore, we confirmed these findings in the arecoline-stimulated BMFs. Consistent with the above findings, the expression of the myofibroblast marker α-smooth muscle actin and other fibrogenic markers, such as type I collagen, fibronectin, and vimentin in fBMFs were all reduced in a dose-dependent manner. Collectively, our data suggested that GMI suppressed the proinflammatory cytokines and myofibroblast features in fBMFs, and could serve as a promising and natural antifibrosis agent.

    Topics: Actins; Arecoline; Cell Movement; Cells, Cultured; Collagen Type I; Cytokines; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibronectins; Fungal Proteins; Ganoderma; Humans; Interleukin-6; Interleukin-8; Mouth Mucosa; Oral Submucous Fibrosis; Vimentin

2018
Areca nut exposure increases secretion of tumor-promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytes.
    International journal of cancer, 2015, Dec-01, Volume: 137, Issue:11

    Molecular crosstalk between cancer cells and fibroblasts has been an emerging hot issue in understanding carcinogenesis. As oral submucous fibrosis (OSF) is an inflammatory fibrotic disease that can potentially transform into squamous cell carcinoma, OSF has been considered to be an appropriate model for studying the role of fibroblasts during early stage carcinogenesis. In this sense, this study aims at investigating whether areca nut (AN)-exposed fibroblasts cause DNA damage of epithelial cells. For this study, immortalized hNOF (hTERT-hNOF) was used. We found that the levels of GRO-α, IL-6 and IL-8 increased in AN-exposed fibroblasts. Cytokine secretion was reduced by antioxidants in AN-exposed fibroblasts. Increase in DNA double strand breaks (DSB) and 8-oxoG FITC-conjugate was observed in immortalized human oral keratinocytes (IHOK) after the treatment of cytokines or a conditioned medium derived from AN-exposed fibroblasts. Cytokine expression and DNA damage were also detected in OSF tissues. The DNA damage was reduced by neutralizing cytokines or antioxidant treatment. Generation of reactive oxygen species (ROS) and DNA damage response, triggered by cytokines, were abolished when NADPH oxidase (NOX) 1 and 4 were silenced in IHOK, indicating that cytokine-triggered DNA damage was caused by ROS generation through NOX1 and NOX4. Taken together, this study provided strong evidence that blocking ROS generation might be a rewarding approach for cancer prevention and intervention in OSF.

    Topics: Antioxidants; Areca; Carcinogenesis; Cells, Cultured; DNA Breaks, Double-Stranded; DNA Damage; Fibroblasts; Gingiva; HEK293 Cells; Humans; Interleukin-6; Interleukin-8; Keratinocytes; Mouth Mucosa; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; Nuts; Oral Submucous Fibrosis; Reactive Oxygen Species

2015
Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
    Clinical oral investigations, 2013, Volume: 17, Issue:2

    Interleukin 8 (IL-8) is a pro-angiogenic, pro-inflammatory mediator that belongs to the family of chemokines. Due to its pro-angiogenic characteristic, it may play a vital role in tumour angiogenesis and progression.. This study was designed to estimate the levels of salivary IL-8 in oral precancer and oral squamous cell carcinoma (OSCC) patients and compare them with healthy controls. The aim was to evaluate its efficacy as a potential biomarker for these diseases.. Each group comprised 25 individuals. The salivary IL-8 levels were determined by enzyme-linked immunosorbent assay.. The levels of salivary IL-8 were found to be significantly elevated in patients with OSCC as compared to the precancer group (p < 0.0001) and healthy controls (p < 0.0001). However, the difference in salivary IL-8 concentrations among the precancer group and controls was statistically non-significant (p = 0.738).. Our results suggested that salivary IL-8 can be utilised as a potential biomarker for OSCC. Salivary IL-8 was found to be non-conclusive for oral premalignancy in this preliminary study. Hence, its possible role in transition from premalignancy to malignancy needs further research with larger sample sizes.. Saliva as a diagnostic biofluid offers a number of advantages over blood-based testing. The role of IL-8 in oral cancer if validated further by future research can provide an easy diagnostic test as well as a prognostic indicator for patients undergoing treatment. Therefore, if it's role in tumourigenesis can be sufficiently assessed, it could open up new avenues to find out novel treatment modalities for oral cancer.

    Topics: Adolescent; Adult; Aged; Angiogenesis Inducing Agents; Areca; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Inflammation Mediators; Interleukin-8; Leukoplakia, Oral; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oral Submucous Fibrosis; Precancerous Conditions; Saliva; Salivary Proteins and Peptides; Smoking; Tobacco Use; Young Adult

2013
Oral submucous fibrosis patients have altered levels of cytokine production.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2000, Volume: 29, Issue:3

    Oral submucous fibrosis (OSF) is a pre-malignant fibrotic lesion of the mouth in betel quid chewers and is characterised by dense bands of collagen in the juxta-epithelial region preceded by inflammation. We have investigated the spontaneous and stimulated production of cytokines by peripheral blood mononuclear cells (PBMC) from OSF patients and compared them with genetically-related relatives, Indian and Caucasian control subjects. The cytokines studied included: interleukin-1beta (IL-1beta), interleukin-6 (IL-6), interleukin-8 (IL-8), tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). The results show: a) significant differences in the stimulated versus non-stimulated levels of IL-1beta, IL-6, IL-8 and TNF-alpha but not of IFN-gamma production by patients, and in the relatives' stimulated versus non-stimulated levels of IL-1beta, IL-6 and IFN-gamma; b) no difference in the spontaneous cytokine production between any two groups; and c) significant increases in the patients' stimulated cytokines compared to the Caucasian and Indian controls (P< or =0.050). These results demonstrate increased levels of proinflammatory cytokines and reduced anti-fibrotic IFN-gamma in patients with OSF, which may be central to the pathogenesis of OSF.

    Topics: Areca; Case-Control Studies; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; India; Interferon-gamma; Interleukin-1; Interleukin-6; Interleukin-8; Oral Submucous Fibrosis; Plants, Medicinal; Tumor Necrosis Factor-alpha; United Kingdom; White People

2000